ENDRAs TAEUS Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Level Results at the Point of Patient Care
ENDRA Life Sciences Inc. (NASDAQ: NDRA) (ENDRA or the Company), a pioneer in thermoacoustic biomarker imaging for the early detection and monitoring of steatotic liver disease (SLD), today announced...